Arkolith/Insider Trading/VINC/Form 4

Hamdy Ahmed MD

See Remarks, DirectorVincerx Pharma, Inc. (VINC) · full profile →Form 4 · filed Aug 10, 2023
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2023Buy(P)5K$0.96$5K96K
Aug 9, 2023Buy(P)17K$0.95$16K91K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-041517) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML